Gonadorelin Analogues
A Modification Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- 4 year
- Value
- £423K-£2M
- Sector
- HEALTH
- Published
- 30 Jan 2024
- Delivery
- To 30 Jan 2028 (est.)
- Deadline
- n/a
Concepts
Location
Edinburgh
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Takeda London
Description
NP90219b Leuprorelin (Prostap®) - The supply of Leuprorelin (Prostap®) to NHS Scotland. The Authority has awarded this Lot as a single supplier framework agreement to one (1) Framework Participant.
Ammendments to Previous Notice
2. Contract value
GBP 1,693,216 2,116,520
Award Detail
| 1 | Takeda (London)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Contract modified due to unforeseen circumstances.
Legal Justification
This modification is necessary to meet the additional demands of the Scottish Health and Social Care sector to maintain necessary supply due to circumstances unforeseen by the Authority, and at this time have rendered this modification necessary, in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.
Other Information
The estimated value of the Framework Agreement referred to in Section V11.1.6 cover(s) the 48 month contract duration of the Framework Agreement. The estimated value in Section V.2.4 covers the additional 12 month extension period of the Framework Agreement. (SC Ref:756519)
Reference
- FTS 003019-2024